Bill > HB1249

This bill establishes the Pennsylvania Drug Shortage Reporting System, which requires manufacturers and wholesale distributors of lifesaving drugs to notify the Department of Health about potential or actual drug shortages. The system mandates that manufacturers must report any permanent discontinuance or interruption in producing a lifesaving drug at least six months in advance, while wholesale distributors must report drug shortages within 72 hours of their occurrence. The Department of Health will create and maintain a public, up-to-date list of lifesaving drugs in shortage, including details such as the drug's name, manufacturer, reason for shortage, and estimated duration. The department will also develop a website where healthcare professionals, patients, and individuals can access information about available stocks of lifesaving drugs and receive alerts when these drugs become available. Additionally, the bill requires the department to submit quarterly reports to legislative committees detailing drug shortage information, actions taken to prevent or mitigate shortages, and interactions with federal agencies like the Drug Enforcement Administration. The system aims to improve transparency and communication about potential drug supply disruptions, ultimately helping to ensure patients have access to critical medications during potential shortages.

Health and Social Services

https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2025&sind=0&body=H&type=B&bn=1249